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Summary 
Recently, we and others have reported tyrosine phosphorylation of phospholipase C-3'1 (PLC3,1) 
enzyme after CD3 activation ofT cells, and have proposed that PLC'yl mediates signal transduction 
through the T cell receptor (TCR/CD3). Here, using immunoblotting and immune complex 
PLC assays, we show that CD3 stimulation of Jurkat cells induces the association  of PLC3,1 
enzyme with CD3 complex. PLC activity is also found to co-precipitate with the CD3~" chain 
from activated cells. In addition, in vitro PLC assays show that CD3 activation leads to about 
10-fold stimulation of PLC't'I activity.  These results,  along with the observation that Jurkat 
cells preferentially express PLC3'I, indicate that PLC3,1 participates in CD3 signaling. 
S 
ignal transduction through the TCR/CD3 complex in- 
duces tyrosine phosphorylation of a number of cellular 
proteins ranging from low to high molecular weights (1-3). 
Inhibition of CD3-induced protein tyrosine kinase activation 
prevents the successful completion of the mitogenic signal 
that controls II.-2 production and T cell proliferation (4, 5). 
Very little is known about the functional significance of tyro- 
sine phosphorylation of these proteins in T  cell activation. 
Recently, several reports have demonstrated that stimulation 
of CD3 leads to tyrosine phosphorylation of phospholipase 
C-'),1 (PLC'yl) enzyme (6-9), which hydrolyzes phosphati- 
dylinositol  4,5-bisphosphate  (PIP2) to  produce  the  two 
second messengers,  inositol trisphosphate (IP3) and diacyl- 
glycerol.  The time course of PLC'y1 tyrosine phosphoryla- 
tion has been found to correlate with the CD3-induced ino- 
sitol phosphate formation and  the  elevation of cytosolic 
Ca  2+ (6, 7). Furthermore, we have also shown that stimu- 
lation of protein kinase C or of cyclic AMP-dependent protein 
kinase, which inhibit PI metabolism and Ca  z  + mobilization 
in T cells (10-12), inhibits PLCT1 tyrosine phosphorylation 
(6). On the basis of these observations, it has been suggested 
that PLCT1 mediates signal transduction via TCR/CD3. The 
present report supports this hypothesis by demonstrating the 
stimulation of PLC'y1 activity and the PLC3~I/CD3 associa- 
tion after ligand binding to the CD3 structure. 
Materials and Methods 
Cells ,z~ Reagen~  Human leukemic T cell line, Jurkat, was 
maintained in media (KPMI 1640, 10% FCS, 50 U/ml penicillin, 
50 #g/ml streptomycin, 2 raM t-glutamine) at a density of 1-2 
x  10  s cells/ml, and the media were changed after every 2 d. 
Cell Lysis and lramunoprecipitation.  Cells  were lysed (40 rain, 
4~  in 1% Triton X-100 and 10% glycerol solution in 50 mM 
Trizma, pH 7.4, with 150 mM NaC1, 1 mM PMSF, 0.26 U/ml 
of aprofinin, 1 mM Na-orthovanadate, 20 mM NaF, and 20 mM 
sodium pyrophosphate.  Precleared  lysates were subjected  to immu- 
noprecipitation  with appropriate  antibodies  (Abs) and immune com- 
plexes were washed as described by us previously (6). 
lmraunoblotting.  Proteins  in imraunoprecipitates  or cell lysates 
were subjected  to SDS-PAGE  and then transferred  to nitrocellulose 
membranes to blot with appropriate Abs as described (6). These 
blots  were developed with  either  nSI-protein A  or  l~I-goat 
anti-mouse IgG Ab (0.4--0.5 #Ci/ml; ICN Chemicals,  Irvine, CA) 
for 2 h at room temperature. After washing, these blots were ex- 
posed to Kodak x-ray films for autoradiography. 
Immunecomplex Phospholipase C Assay.  These assays were per- 
formed as described by us previously (6). 
Results end Discussion 
In vitro measurements of PLC activity show that antiphos- 
photyrosine (APTyr) Ab isolates ~10-fold or more of the ac- 
tivity from stimulated T  cells as compared with that from 
nonstimulated  cells (6-8). Maximal activity is obtained within 
2 rain of CD3 activation, followed by a subsequent reduction 
after 10 min (6).  Since changes in APTyr Ab-bound PLC 
activity have been found to correlate with alterations in the 
level of PLCT1 tyrosine phosphorylation and the degree of 
CD3-induced Ca  2  + mobilization (6), this enzyme has been 
proposed to mediate the signal transduction via the TCR/CD3 
structure. 
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activation, it was decided first of all to examine if the APTyr 
Ab-bound PLC activity was due to PLC~/1. To achieve this, 
CD3-activated Jurkat cells were lysed and then subjected to 
immunoprecipitation with APTyr Ab. The presence of  PLC3d 
in these immune complexes was detected by immunoblot- 
ting with an anti-PLC3d Ab. From parallel samples PLC'yl 
was also immunoisolated and subjected to similar analysis. 
These experiments demonstrate that APTyr Ab used in PLC 
assays binds to PLC3'I enzyme (Fig.  1, lane B). Since these 
experiments were performed with excess amounts of APTyr 
and anti-PLC'y1 Abs, comparison of counts present in PLCqd 
bands (lanes B vs. D) indicates that ~g5% of the cellular PLC~/1 
enzyme is precipitated with APTyr Ab. However, under similar 
conditions of precipitation, PLC'y1 present in APTyr Ab im- 
munoprecipitate accounts for 60-70%  of the total PLC~,I 
activity from stimulated T cells. For example, a representative 
experiment shows that PLC~/1 isolated from 3 min-activated 
Jurkat cells  (5  x  106  cells/sample)  using anti-PLC3,1  and 
APTyr Abs produces 4,162 and 3,050 pmols oflP3 in 30 min, 
respectively. This indicates that CD3-induced tyrosine phos- 
phorylation of PLC'y1 enhances its enzymatic activity. 
To further examine the stimulation of PLC~/1 activity after 
CD3 activation, the enzyme was precipitated from activated 
and nonactivated cells, and PLC activities were measured. As 
described in the case of EGF receptor stimulation (14), we 
detected CD3-mediated stimulation of PLC3d activity. The 
enzyme isolated from activated T cells has 1.3-1.7 times higher 
activity than the one from nonactivated cells (Table 1) (n  = 
4).  Maximal stimulation of enzyme activity was detected 
within 2 min of CD3 activation, which gradually decreases 
to the control level. Therefore, considering that ,v5% of the 
cellular PLC~/1 is tyrosine phosphorylated, the present data 
demonstrate 7-15%-fold stimulation of PLC3,1 activity after 
CD3 activation. Taken together, these results indicate an in- 
volvement of PLC~/1 in TCR signaling. 
Figure 1.  CD3-induced  tyrosiae  phosphoryhtion  of PLC3,1.  Jurkat  cells 
(2  x  107/2 ml/sampie)  in RPMI 1640 west treated  with (A, B, and E) 
or without (C, D, and F) anti-CD3 Ab OKT3 (3/~g/ml) for 3 min at 
37~  lysed,  and then  precipitated with (,4) control  Ab ST2-59 against 
HLA-DK  molecules,  (B and C) antiphosphotyrosine  Ab 4G10 (reference 
13), (D) and-PLC~l  Ab, and (E and F) protein A-SepharoSe  beads alone 
for background. These precipitates were subjected to SDS-PAGE and 
processed for immuaoblotting  with anti-PLC3,1  Ab. Membranes  were  ex- 
posed to X-OMAT Kodak  films  for 3 d at -70~  for autoradiography. 
Table  1.  Activation of PLC71  after CD3 Stimulation 
Treatment  of cells  pmol of IP3 formed/20  min 
Nonactivated  601.8 
Activated (1 rain)  1029.3 (1.71 x ) 
Activated (5 rain)  862.5  (1.43 x ) 
Activated (10 min)  751.3  (1.25 x ) 
Jurkat cells (5  x  106/0.5 ml/sample) were stimulated with OKT3 
(3/zg/ml) for different  time periods and then lysed in 200/~1 of lysis 
buffer. From precleared lysates, PLC3'I was precipitated, and the PLC 
activities present in immune  complexes  were determined  in the presence 
of 0.05% Triton X-100 (14) and 0.125% of octyl-glucoside.  For details, 
see Materials  and Methods. The specific  activity  of [3H]PIP2 was 1,200 
cpm/nmol. 
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Figure 2.  Precipitation  of PLC activity  with CD3 complex. (.4) Pre- 
cooled Jurkat cells (107/ml/sample) in RPMI 1640 were treated with 
OKT3 (3/~g/ml) on ice for 7 min and then transf*rred  to 37~  At indi- 
cated time points, cells were quickly  washed and lysed  in 250/~1 of lysis 
buffer as described  Materials  and Methods. From  these  lysates  CD3 com- 
plexes were immunoprecipitated  on protein A-Sepharose  beads and PLC 
activities  were measured  as described  in Materials  and Methods. (B) Cell 
1)~ates  prepared  as above  were  subjected  to immunopredpitation  with  AFryr- 
Ab, and PLC activities  were measured  in these complexes. The specific 
activity of [3H]PIP2 was 2,700 cpm/nmol. 
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(107/ml) were activated  with OKT3 for 5 min at 37~  and CD3 com- 
plexes were immunoprecipitated  as described  in the legend  to Fig. 2 A. 
Control immunoprecipitates  using  mouse  IgG (A) and CD3-immune  com- 
plexes (C) from  3 x  107 activated  cells, and 6 x  l0  s cell lysate  (B) were 
processed  for immtmoblotting  with anti-PLC3d.  For autoradiography,  mem- 
branes were exposed to X-OMAT Kodak films for 3 d at  -70*C. 
The ligand binding to epidermal growth factor (EGF) and 
platelet-derived growth factor (PDGF) receptors have been 
shown  to  promote  PLC3'  association  with  the  receptors 
(15-17).  In our experiments, association of PLC activity with 
the CD3 structure was first indicated by the observation that, 
within 2-3 min of activation, a low but significant amount 
of PLC  activity (180-340  pmol  IP3  formed/30 min) was 
precipitated by anti-CD3~'Ab (n  =  4). CD3~'protein forms 
a complex with TCR/CD3  and apparently plays  a crucial 
role in signal transduction (18). However, variable results were 
obtained when CD3-anti-CD3 complexes, isolated from the 
activated cell lysates, were tested for the presence of PLC ac- 
tivity. This variation could be due to relatively weak binding 
and a rapid dissociation of OKT3 Ab from CD3  at 37~ 
(19). Therefore, instead of adding anti-CD3 to T cells at 37~ 
precooled T  cells were coated with OKT3  Ab at 4~  for 
7-8  min, where the binding is largely bivalent,  complete, 
and stronger (19). The precoated cells were then transferred 
to 37~  to induce CD3 stimulation. Using this procedure, 
PLC activity was found to co-precipitate with the CD3 struc- 
ture in a reproducible manner (n  =  6). The level of activity 
associated with the CD3 complex after 4-6 min of activa- 
tion ranges from 478  to 805  pmol of IP3 formed/30 min 
(n =  4). The data from a representative experiment are shown 
in Fig. 2 A. In parallel experiments, APTyr Ab precipitated 
a high level of PLC activity from cell lysates  (Fig.  2 B) (n 
=  4),  consistent with the increased PLC3,1 tyrosine phos- 
phorylation (data not shown). Similar experiments performed 
with anti-CD45RO  Ab,  UCHL1,  do not show precipita- 
tion of PLC activity with CD45KO Ag, indicating a specific 
association of PLC activity with  the CD3  structure. 
To determine if this activity is due to PLC3,1, CD3 com- 
plexes  immunoprecipitated  from  the  lysates  of  activated 
T  cells were subjected to SDS-PAGE,  and the presence of 
PLC3~I was detected by immunoblotting with anti-PLC~/1 
Ab. Fig. 3 shows that CD3 complex from activated cells con- 
rains PLC'y1 (lane C-'). Radioactive counts present in the PLC'y1 
protein band precipitated with CD3 complex from 3  x  107 
Jurkat cells (Fig. 3, lane C) are about one half of that in PLCqrl 
from 6  x  l0  s Jurkat cell lysate (Fig.  3, lane B), indicating 
,vl%  of the cellular PLC~/1 in association with the CD3 
structure. 
The present work demonstrates that CD3  activation of 
T  cells leads to the association of PLC~/1 enzyme with the 
CD3 complex and also stimulates its enzymatic activity. These 
results, along with the observation that Jurkat cells preferen- 
tially express  PLC~I  and not PLC3,2  (results not shown), 
indicate that the former isozyme of PLC mediates TCR/CD3 
signaling.  Although in comparison with EGF and PDGF 
receptor stimulation, the extent of CD3-induced PLC3~I tyro- 
sine phosphorylation and its association with the CD3 com- 
plex is small, these values appear consistent when the density 
of CD3 on T  cells (2  x  104/cell; reference 19) is compared 
with that of EGF or PDGF receptors (1.5-5  x  10S/cell; ref- 
erence 20).  The CD3/PLC3,1  association observed in acti- 
vated cells apparently indicates that CD3-1inked protein tyro- 
sine kinase p59~ (1) may be responsible for PLC3,1 tyrosine 
phosphorylation. However, a fairly high level of  PLC3,1 tyro- 
sine phosphorylation occurs before a significant CD3/PLC3,1 
association (Fig. 2), suggesting that in T cells increased tyro- 
sine phosphorylation of PLC3,1 does not correlate with its 
association with the CD3 structure. Similar observations were 
made in NIH3T3 cells where, despite low levels of tyrosine 
phosphorylation, mutant PLC3,1 associates with the PDGF 
receptor  (21).  On  the  contrary,  in  HER14  cells  PDGF- 
mediated PLC3,1 tyrosine phosphorylation does not induce 
EGF receptor/PLC3,1 association  (20). These studies suggest 
that the association of PLC3,1 with receptor molecules de- 
pends upon the biochemical state of the latter, perhaps deter- 
mined by their phosphorylation. Therefore, the question to 
be addressed is whether the cytosolic or the TCR/CD3-bound 
protein tyrosine kinase phosphorylates PLC3,1 after CD3 ac- 
tivation of T  cells. 
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